As of November 10, 2026, Edwards Lifesciences Corp is a publicly traded company (NYSE: EW); its largest reported holder is Vanguard, with 7.54% on Schedule 13G of April 29, 2026, then BlackRock (7.5%). The largest insider holding is Scott B. Ullem, the chief financial officer and cvp, with 313,058 shares (0.05% of shares outstanding), per Form 4 of May 11, 2026 (Schedule 13G, April 29, 2026).
Is this your company?
About to sign with, pay or invest in Edwards Lifesciences Corp? See the free Snapshot first.
Free to see. No signup.
Is Edwards Lifesciences Corp a real, registered company?
- Edwards Lifesciences Corp files with the SEC under CIK 1099800 (its SEC filings).
- Its shares are listed under the ticker EW on NYSE (SEC company record).
- Incorporated in Delaware; business address in Irvine, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Edwards Lifesciences Corp in our court records and SEC 8-K records (as of 2026-11-10).
- Leadership changes: the latest reported is Theodora Mistras, Chief Financial Officer (Form 8-K filed 2026-05-04). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Vanguard (filed 2026-04-29).
Who are Edwards Lifesciences Corp's owners and officers?
Edwards Lifesciences Corp: incorporated in Delaware; business address in Irvine, California; industry Orthopedic, Prosthetic & Surgical Appliances & Supplies (Form D, 2026-05-04).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-04-29 | Vanguard Capital Management | 7.54% |
| Schedule 13G/A, 2026-03-26 | The Vanguard Group | 0% |
| Schedule 13G/A, 2025-10-17 | Blackrock, Inc. | 7.5% |
| Schedule 13G/A, 2025-08-12 | Wellington Management Group LLP | 3.4% |
Questions about who owns Edwards Lifesciences Corp
Who owns Edwards Lifesciences Corp?
On this page, 2 holders' latest ownership filings report 5% or more of Edwards Lifesciences Corp: Vanguard Capital Management (7.54%, Schedule 13G, filed 2026-04-29) and Blackrock, Inc. (7.5%, Schedule 13G/A, filed 2025-10-17).
Who are the largest shareholders of Edwards Lifesciences Corp?
By the share each holder's latest filing reports, the largest holders of Edwards Lifesciences Corp on this page are Vanguard Capital Management (7.54%) and Blackrock, Inc. (7.5%).
When did Vanguard Capital Management buy into Edwards Lifesciences Corp?
The filings give report dates, not purchase dates. The earliest filing from Vanguard Capital Management on this page is the Schedule 13G, filed 2026-04-29, reporting 7.54%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Edwards Lifesciences Corp?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Edwards Lifesciences Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Edwards Lifesciences Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-05-04 | Theodora Mistras | Chief Financial Officer | appointed | 2026-05-29 |
Which insiders own Edwards Lifesciences Corp shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chief financial officer and cvp: 313,058 shares (0.05% of shares outstanding), 46,740 held directly and 266,318 indirectly (Form 4, 2026-05-11).
- , the president and surg: 207,048.56 shares (0.04% of shares outstanding), 206,900.39 held directly and 148.17 indirectly (Form 4, 2025-08-18).
- , the cvp and strategy: 152,378.829 shares (0.03% of shares outstanding), 22,798.253 held directly and 129,580.576 indirectly (Form 4, 2026-11-09).
- , the chief executive and a director: 111,494.21 shares (0.02% of shares outstanding), 98,845 held directly and 12,649.21 indirectly (Form 4, 2026-11-09).
- , the chief financial officer and cvp: 99,920 shares (0.02% of shares outstanding) (Form 4, 2026-07-10).
Shares outstanding: 575,000,000 as of 2026-10-31, from the company's latest SEC cover page.
How much has Edwards Lifesciences Corp raised?
No fundraising or offering filing from Edwards Lifesciences Corp is on file with us.
Keep reading
More on Edwards Lifesciences Corp and the records around it.
Edwards Lifesciences Corp elsewhere on the record
- Leadership changes Aug 2026
Companies that share a holder
- Wellington Management Group LLP also filed stake reports on 240 other companies: Hub Group, Inc. (Oct 2026), Latham Group, Inc. (Oct 2026), Redwood Trust, Inc. (Oct 2026)
- Vanguard Capital Management also filed stake reports on 1495 other companies: A10 Networks Inc (Oct 2026), Altisource Portfolio Solutions SA (Oct 2026), Alto Neuroscience Inc (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/edwards-lifesciences